Tag: innate
Sanofi: extended collaboration with Innate Pharma – 12/19/2022 at 07:43
(CercleFinance.com) – Sanofi and Innate Pharma announce the expansion of their collaboration, which grants Sanofi a license to the Natural Killer (NK) cell-engaging antibody program targeting the B7-H3 protein from…
Innate Pharma: Stifel remains to buy
(CercleFinance.com) – Stifel reaffirms its ‘buy’ recommendation and its target price of 5.7 euros on Innate Pharma, a ‘significantly undervalued’ stock according to him, after the announcement of an extension…
Innate and Sanofi extend their collaboration for the development of NK cells in Oncology – 12/19/2022 at 08:52
(AOF) – Innate Pharma and Sanofi have announced the extension of their collaboration for the development of NK cells in Oncology. Under the terms of the new licensing agreement, Innate…
Innate Pharma: Oddo welcomes the agreement with Sanofi
(CercleFinance.com) – Oddo BHF reiterates its ‘outperformance’ recommendation on Innate Pharma, as well as its target price of seven euros, following the announcement of an extension of the collaboration between…
Sanofi: Extended collaboration with Innate Pharma
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Innate jumps after expanding collaboration with Sanofi – 12/19/2022 at 09:17
(AOF) – Biggest rise in the SRD market, Innate Pharma soared more than 15% to 2.37 euros, galvanized by the extension of its collaboration with Sanofi for the development of…
Sanofi: expanded collaboration with Innate Pharma
(CercleFinance.com) – Sanofi and Innate Pharma announce the expansion of their collaboration, which grants Sanofi a license to the Natural Killer (NK) cell-engaging antibody program targeting the B7-H3 protein from…
Innate Pharma: Data presented on lacutamab at ASH – 12/12/2022 at 10:08
(CercleFinance.com) – Innate Pharma reports that it has presented data from a preliminary analysis of the Phase II Tellomak trial demonstrating clinical activity and a favorable safety profile for lacutamab,…
Innate Pharma: nine-month turnover more than quadrupled – 11/14/2022 at 07:43
(CercleFinance.com) – On the occasion of its activity update, the biotechnology company Innate Pharma posted a turnover for the first nine months of 2022 of 44.3 million euros, compared to…
Innate Pharma posts a sharp increase in its turnover – 11/14/2022 at 08:07
(AOF) – Innate Pharma, a clinical-stage biotechnology company specializing in immuno-oncology, has announced sales for the first nine months of 2022 of around 44.3 million euros compared to 10, 3…
Innate Pharma: nine-month turnover more than quadrupled
(CercleFinance.com) – On the occasion of its activity update, the biotechnology company Innate Pharma posted a turnover for the first nine months of 2022 of 44.3 million euros, compared to…
Innate Pharma: appointment to follow
HC Published on 02/11/2022 at 07:48 (Boursier.com) — Innate…